Cargando…

Thromboembolism after Astra Zeneca COVID-19 vaccine: Not always PF4- antibody mediated

Cases of thromboembolic events in 2021 flared up the discussion about the safety of Astra Zeneca’s AZD1222 vaccine. We hereby report three cases of pulmonary embolism (PE), one case of extended portal vein thrombosis, and one case of combined portal vein thrombosis and PE within 2 weeks after vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales:	d’Almeida, Sascha, Markovic, Sinisa, Hermann, Patrick, Bracht, Hendrik, Peifer, Johannes, Ettrich, Thomas J., Imhof, Armin, Zhou, Shaoxia, Weiss, Manfred, Viardot, Andreas, Rottbauer, Wolfgang, Dahme, Tillman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Coronavirus
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478733/ https://www.ncbi.nlm.nih.gov/pubmed/37655367 http://dx.doi.org/10.1080/21645515.2023.2252239

Ejemplares similares

AstraZeneca COVID-19 vaccine-related thromboembolism
Publicado: (2021)

Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence?
por: Østergaard, Søren Dinesen, et al.
Publicado: (2021)

Adverse events of Oxford/AstraZeneca's COVID-19 vaccine among health care workers of Ayder Comprehensive Specialized Hospital, Tigray, Ethiopia
por: Tequare, Mengistu Hagazi, et al.
Publicado: (2021)

Evaluation and comparison of post-vaccination adverse effects among Janssen and Oxford-AstraZeneca vaccinated adult individuals in Debre Tabor Town: A cross- sectional survey in Northwest Ethiopia
por: Chekol Abebe, Endeshaw, et al.
Publicado: (2022)

AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021)

Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Publicado: (2021)

Vaccin Oxford/AstraZeneca, mode d’emploi
por: Dalmat, Yann-Mickael
Publicado: (2021)

Oxford–AstraZeneca COVID-19 vaccine efficacy
por: Knoll, Maria Deloria, et al.
Publicado: (2021)

Bleeding and clotting with AstraZeneca's COVID-19 vaccine
Publicado: (2021)

AstraZeneca COVID-19 vaccine: no increased rate of VTE
Publicado: (2021)

No increased risk of anaphylaxis with AstraZeneca COVID-19 vaccine
Publicado: (2021)

Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine
por: Agharbi, F.-Z., et al.
Publicado: (2022)

AstraZeneca COVID-19 vaccine-related thrombocytopenia and thrombosis
Publicado: (2021)

Canadian findings on AstraZeneca COVID-19 Vaccine and COVISHIELD
Publicado: (2021)

AstraZeneca COVID-19 vaccine recommended in ≥50s in Australia
Publicado: (2021)

Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines
por: Mahallawi, Waleed H., et al.
Publicado: (2021)

Risk-benefit of AstraZeneca COVID-19 vaccination in Australia
Publicado: (2021)

Ischemic stroke after AstraZeneca (Covid-19) vaccination
por: Alammar, Muath A.
Publicado: (2021)

Lipschütz ulcers after AstraZeneca COVID-19 vaccination()
por: Bracho-Borro, Maria, et al.
Publicado: (2023)

Health Canada: blood clots with AstraZeneca's COVID-19 vaccine
Publicado: (2021)

Denmark ceases roll out of AstraZeneca's COVID-19 vaccine
Publicado: (2021)

Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis
por: Allen-Philbey, K., et al.
Publicado: (2021)

Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine()
por: Crespo Burillo, J.A., et al.
Publicado: (2021)

Superficial Thrombophlebitis of the Penis following AstraZeneca ChAdOx1-S Vaccination: A Rare Venous Thromboembolic Complication
por: Winston, Joshua, et al.
Publicado: (2022)

Deferral of Non-Emergency Cardiovascular Interventions Triggers Increased Cardiac Emergency Admissions—Analysis of the COVID-19 Related Lockdown
por: Felbel, Dominik, et al.
Publicado: (2022)

Benefits of COVID-19 Vaccine AstraZeneca outweigh risks of blood clots
Publicado: (2021)

AstraZeneca COVID-19 vaccine not recommended in adults under 55 in Canada
Publicado: (2021)

Ongoing evaluation of COVID-19 Vaccine AstraZeneca-related blood clots
Publicado: (2021)

Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine
por: Morlidge, Clare, et al.
Publicado: (2021)

An analysis of AstraZeneca COVID-19 vaccine misinformation and fear mongering on Twitter
por: Jemielniak, D., et al.
Publicado: (2021)

Thrombocytopenic purpura with AstraZeneca but not Pfizer-BioNTech COVID-19 vaccine
Publicado: (2021)

Vaccin AstraZeneca et événements thrombo-emboliques : l’EMA enquête
por: Manus, Jean-Marie
Publicado: (2021)

AstraZeneca COVID-19 Vaccine-related risk of capillary leak syndrome
Publicado: (2021)

Increased risk of immune thrombocytopenia following AstraZeneca Covid-19 vaccine
Publicado: (2021)

Who funded the research behind the Oxford–AstraZeneca COVID-19 vaccine?
por: Cross, Samuel, et al.
Publicado: (2021)

Morbilliform Eruption After Administration of Second Dose of Oxford/AstraZeneca Vaccine
por: Alhammad, Norah S, et al.
Publicado: (2022)

[Translated article] Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine
por: González-Romero, N., et al.
Publicado: (2022)

A Case Report of Exfoliative Bullous Rash Following AstraZeneca Vaccine
por: Saleem, Usman, et al.
Publicado: (2022)

Systemic lupus erythematosus with acrocyanosis after AstraZeneca COVID‐19 vaccination
por: Wang, Huei‐Jing, et al.
Publicado: (2022)

Erythema nodosum following the first dose of AstraZeneca COVID-19 vaccine
por: Berrim, K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2rjtqdhfsh12mv92gho62nt0ud